ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Ubiquitin specific peptidase 11 as a novel therapeutic target for cancer management

Liao, Yihao; Zhou, Diansheng; Wang, Pu; Yang, Mengyue; Jiang, Ning*哈尔滨医科大学
Cell Death Discovery2022-6-17DOI: 10.1038/s41420-022-01083-5
6被引11阅读
引用收藏
分享

摘要

Ubiquitination is a critical biological process in post-translational modification of proteins and involves multiple signaling pathways in protein metabolism, apoptosis, DNA damage, cell-cycle progression, and cancer development. Deubiquitinase, a specific enzyme that regulates the ubiquitination process, is also thought to be closely associated with the development and progression of various cancers. In this article, we systematically review the emerging role of the deubiquitinase ubiquitin-specific peptidase 11 (USP11) in many cancer-related pathways. The results show that USP11 promotes or inhibits the progression and chemoresistance of different cancers, including colorectal, breast, ovarian, and hepatocellular carcinomas, via deubiquitinating several critical proteins of cancer-related pathways. We initially summarize the role of USP11 in different cancers and further discuss the possibility of USP11 as a therapeutic strategy.

学科与关键词

关键词
DEUBIQUITINATING ENZYMECOLORECTAL-CANCERBREAST-CANCERLUNG-CANCERCARCINOMA METASTASISCELL-PROLIFERATIONSIGNALING PATHWAYGASTRIC-CANCERIN-VIVOUSP11
相关
加载中…
  • The emerging role of ubiquitin-specific protease 20 in tumorigenesis and cancer therapeutics
    Li, Qiong; Ye, Chanqi; Tian, Tian; Jiang, Qi; Zhao, Peng; Wang, Xiaoting; Liu, Feiye; Shan, Jianzhen; Ruan, Jian*Cell Death & Disease, 2022, 13(5): 434.被引 11
  • Deubiquitinases in Cancers: Aspects of Proliferation, Metastasis, and Apoptosis
    Liu, Jiaqi; Leung, Chi Tim; Liang, Luyun; Wang, Yuqin; Chen, Jian*; Lai, Keng Po; Tse, William Ka Fai*Cancers, 2022, 14(14): 3547.被引 9
  • Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor?
    Liao, Yihao; Yang, Mengyue; Wang, Keke; Wang, Youzhi; Zhong, Boqiang; Jiang, Ning*Cancer Letters, 2022, 526: 248-258.被引 17
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Death Discovery
发表日期
2022-06-17
卷期
第 8 卷, 第 1 期
页码
292
DOI
10.1038/s41420-022-01083-5
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81872079, 81572538]; Science Foundation of Tianjin [11JCZDJC19700, ZC20131, 16JCZDJC34400, 20140117, 16KG118]

作者

  • L

    Liao, Yihao (第一作者)

    2 · tianjin med univ

  • Z

    Zhou, Diansheng

    2 · tianjin med univ

查看全部 5 位作者收起作者
  • W

    Wang, Pu

    2 · tianjin med univ

  • Y

    Yang, Mengyue

    2 · harbin med univ

  • J

    Jiang, Ning (通讯)

    2 · tianjin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417